INVH P/E Ratio Analysis
Updated 153h ago·SEC filings & market data
Key Takeaway
The P/E ratio of 27.9x means investors pay $27.90 for every $1.00 of the company's trailing earnings per share.
Sector Performance
61th percentileINVH
27.9x
Sector Median
23.1x
Sector Avg
33.7x
Prior Period
32.1x(Jul 2026)
Deep Analysis
The P/E ratio of 27.9x means investors pay $27.90 for every $1.00 of the company's trailing earnings per share.
This is above the sector median of 23.3x, placing INVH in the 60th percentile among sector peers, so it is more expensive than most comparable companies. The year-over-year change is not available, but the quarter-over-quarter change is -12.9%, with the ratio falling from 32.1x to 27.9x. The combination of a level above the sector median with a declining QoQ trend suggests valuation risk is still present but easing, as the stock's price has become less stretched relative to earnings. This does not contradict the NEUTRAL verdict; it supports it by showing a premium valuation that is moderating, leaving neither clear downside nor upside pressure from this metric alone.
Frequently Asked Questions
What does the P/E Ratio tell investors about INVH?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
Who are INVH's closest peers by P/E Ratio?
The closest peers by P/E Ratio include: WELL (102.4x), IAC (104.9x), FORM (108.1x), MCHP (113.5x), MTSI (118.9x).
Learn More About P/E Ratio
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master INVH's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full INVH research report →INVH
27.9x
Sector Median
23.1x
Sector Avg
33.7x
How INVH's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.